Fact CheckerSign in

NCT07636889Completed

Effectiveness of a BEFAST-Based Stroke Education Module on Knowledge, Attitudes and Practices Among Stroke Patients at a Malaysian Tertiary Hospital: A Pre-Post Intervention Study

Source: ClinicalTrials.gov · Last updated 9 Jun 2026

Brief summary (registry, in English)

Stroke is a major health problem in Malaysia. Many stroke patients do not know how to recognize stroke symptoms quickly or when to seek emergency help. The BEFAST mnemonic (Balance, Eyes, Face, Arm, Speech, Time) is a simple tool to help people remember stroke warning signs. This study tests whether a single stroke education session based on BEFAST improves knowledge, attitudes, and emergency response intentions among stroke patients admitted to a Malaysian tertiary hospital. The study will use a pre-post intervention design with follow-up at one month. Participants will be the stroke patients admitted to the neurology ward. They will receive a one-hour structured education module covering BEFAST symptoms, risk factors, and the importance of reaching a hospital within 4.5 hours. Education will is delivered by doctors and nurses using presentations, pamphlets, posters, videos, and follow-up WhatsApp messages. Outcomes will be assessed using a validated questionnaire measuring knowledge, attitudes, and practices at three time points: before the intervention, immediately after, and at one month. Associations between demographic factors and outcomes will also be explored.

Status (registry)
Completed
Study type
Interventional
Enrollment
112 (actual)
First submitted
25 May 2026
Start date
1 Sept 2024
Primary completion date
1 Sept 2025
Lead sponsor
Hospital Pengajar Universiti Putra Malaysia
Diseases
Stroke
NCT number
NCT07636889

What you commit to

  • Study type: Interventional
  • Participants enrolled: 112
  • From 1 Sept 2024 to the primary completion date, 1 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous documented diagnosis of dementia or other neurodegenerative conditions

Other illness

  • Significant cognitive impairment preventing informed consent

Age

  • Under 18 years of age

Other

  • Severe aphasia precluding meaningful participation as assessed by speech-language pathologists
  • Too medically unstable to participate as determined by the clinical team
  • Severe visual or hearing impairments preventing educational material comprehension
  • Expected to be discharged within 24 hours of admission

Who the study is looking for

  • Over 18 years old
  • Diagnosed with acute stroke (either ischemic or hemorrhagic) confirmed via MRI or CT scan according to WHO criteria
  • Clinically stable as determined by the attending neurologist using standardized assessment protocols
  • Cognitively able to participate
  • Able to understand Malay or English language as confirmed through structured communication assessment

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital Pengajar Universiti Putra Malaysia/ Hospital Sultan Abdul Aziz Shah UPM
Coordinator of this site? Confirm its status
SerdangMalaysiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.